- Wound Aetiologies, Patient Characteristics, and Healthcare Settings Amenable to Maggot Therapy
- Ronald A. Sherman (author)
- Frank Stadler(author)
Export Metadata
| Title |
|
|---|---|
| Contributor | Ronald A. Sherman (author) |
| Frank Stadler(author) | |
| DOI | https://doi.org/10.11647/obp.0300.03 |
| Landing page | https://www.openbookpublishers.com/books/10.11647/obp.0300/chapters/10.11647/obp.0300.03 |
| License | https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright | Ronald A. Sherman; Frank Stadler |
| Publisher | Open Book Publishers |
| Publication place | Cambridge, UK |
| Published on | 2022-07-20 |
| Long abstract | It is important for healthcare practitioners to understand when to use maggot therapy. This chapter explains the general factors that determine the choice of wound treatment and how they apply to maggot therapy: i) the wound characteristics, ii) the patient characteristics, iii) the environment, iv) the available resources, and v) the specific characteristics of each available treatment modality. Beyond the regular healthcare setting, maggot therapy can make a significant contribution to the treatment of people with wounds in compromised healthcare settings such as in times of disaster and armed conflict, in underserved populations, or in palliative care. |
| Page range | pp. 39–62 |
| Language | English (Original) |
Contributors
Ronald A. Sherman
(author)Ronald A. Sherman retired from the University of California, Irvine in 2008 in order to devote his time to teaching, research, and patient-care activities using medicinal animals. He has studied maggot therapy for over forty years, and began the first controlled clinical trials of maggot therapy in 1990. In 2004, the Medical Maggots™ which he developed at the University of California became the first living organism to be granted marketing clearance by the U.S. Food and Drug Administration as a medical device. He holds degrees in entomology, medicine, and clinical tropical medicine. Ronald Sherman is Director of the BioTherapeutics, Education and Research (BTER) Foundation, which develops educational and research programmes in biotherapy, and he is Co-Founder and Laboratory Director of Monarch Labs, which produces medicinal animals in North America. He does not accept financial support for either of these positions, nor for any of his maggot therapy teaching or research. Instead, he earns his living working in an unrelated field, as an HIV/AIDS physician for the county health department. His wife, however, is paid a salary for working in the maggot lab, day and night.
Frank Stadler
(author)Frank Stadler is the owner and director of Similitude Pty Ltd and MedMagLabs. He is also the Centre Manager at the ARC Training Centre for the Facilitated Advancement of Australia's Bioactives (FAAB) and Adjunct Fellow at Applied BioSciences, Macquarie University. At Griffith University, Frank holds an Adjunct Research Fellow position with the School of Medicine and Dentistry. For the past eight years he has conducted world-first research on supply chain management for maggot therapy in compromised healthcare settings. Frank has held positions in research, research management, science communication, and project management. He has curated a natural history museum, owned an environmental education business, and managed a multi-million-dollar portfolio of research at the National Climate Change Adaptation Research Facility, Griffith University. Frank has extensive expertise in maggot therapy and its supply chain management, invertebrate biology, and laboratory rearing of invertebrates. He and his colleagues established MedMagLabs, a two-year research and development project funded by Creating Hope in Conflict: A Humanitarian Grand Challenge, to develop medicinal maggot production and maggot therapy solutions for conflict-affected isolated communities. This work has motivated Frank to transition MedMagLabs in 2021 from a university research lab into a for-purpose private enterprise under the governance of Similitude Pty Ltd.
References
- 1. Nigam, Y. and M.R. Wilson, Maggot Debridement, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 143–152, https://doi.org/10.11647/OBP.0300.08.(opens in new tab)
- 2. Nigam, Y. and M.R. Wilson, The Antimicrobial Activity of Medicinal Maggots, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 153–174, https://doi.org/10.11647/OBP.0300.09.(opens in new tab)
- 3. Nigam, Y. and M.R. Wilson, Maggot-assisted Wound Healing, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 175–194, https://doi.org/10.11647/OBP.0300.10.(opens in new tab)
- 4. Bullen, B. and P. Chadwick, Clinical Integration of Maggot Therapy, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 97–118, https://doi.org/10.11647/OBP.0300.06.(opens in new tab)
- 5. Falabella, A.F., Debridement and Wound Bed Preparation. Dermatologic Therapy, 2006. 19(6): pp. 317–325, https://doi.org/10.1111/j.1529-8019.2006.00090.x. (opens in new tab)
- 6. Weir, D., P. Scarborough, and J. Niezgoda, Wound Debridement, in Chronic Wound Care: The Essentials, D.L. Krasner and L. van Rijswijk (eds). 2018, HMP Communications: Malvern, PA, pp. 63–78.
- 7. Sherman, R.A., Mechanisms of Maggot-Induced Wound Healing: What Do We Know, and Where Do We Go from Here? Evidence-based Complementary and Alternative Medicine, 2014. 2014: pp. 1–13, https://doi.org/10.1155/2014/592419. (opens in new tab)
- 8. Greenberg, B., Model for Destruction of Bacteria in the Midgut of Blow Fly Maggots. Journal of Medical Entomology, 1968. 5(1): pp. 31–38, https://doi.org/10.1093/jmedent/5.1.31. (opens in new tab)
- 9. Mumcuoglu, K.Y., et al., Destruction of Bacteria in the Digestive Tract of the Maggot of Lucilia sericata (Diptera: Calliphoridae). Journal of Medical Entomology, 2001. 38(2): pp. 161–166, https://doi.org/10.1603/0022-2585-38.2.161. (opens in new tab)
- 10. Bian, H., et al., Beneficial Effects of Extracts from Lucilia sericata Maggots on Burn Wounds in Rats. Molecular Medicine Reports, 2017. 16(5): pp. 7213–7220, https://doi.org/10.3892/mmr.2017.7566. (opens in new tab)
- 11. Erdmann, G.R. and S.K. Khalil, Isolation and Identification of Two Antibacterial Agents Produced by a Strain of Proteus Mirabilis Isolated from Larvae of the Screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). Journal of Medical Entomology, 1986. 23(2): pp. 208–211, https://doi.org/10.1093/jmedent/23.2.208. (opens in new tab)
- 12. Gordya, N., et al., Natural Antimicrobial Peptide Complexes in the Fighting of Antibiotic Resistant Biofilms: Calliphora Vicina Medicinal Maggots. PloS ONE, 2017. 12(3): e0173559, https://doi.org/10.1371/journal.pone.0173559. (opens in new tab)
- 13. Pöppel, A.-K., et al., Antimicrobial Peptides Expressed in Medicinal Maggots of the Blow Fly Lucilia sericata Show Combinatorial Activity against Bacteria. Antimicrobial Agents and Chemotherapy, 2015. 59(5): pp. 2508–2514, https://doi.org/10.1128/AAC.05180-14. (opens in new tab)
- 14. Teh, C.H., et al., Determination of Antibacterial Activity and Minimum Inhibitory Concentration of Larval Extract of Fly via Resazurin-based Turbidometric Assay. BMC Microbiology, 2017. 17(1): pp. 36–36, https://doi.org/10.1186/s12866-017-0936-3. (opens in new tab)
- 15. Wright, E.A. and E.R. Pavillard, An Antibiotic from Maggots. Nature, 1957. 180(4592): pp. 916–917, https://doi.org/10.1038/180916b0. (opens in new tab)
- 16. Bohova, J., et al., Selective Antibiofilm Effects of Lucilia sericata Larvae Secretions/Excretions against Wound Pathogens. Evidence-Based Complementary and Alternative Medicine, 2014. 2014: pp. 857360–857360, https://doi.org/10.1155/2014/857360. (opens in new tab)
- 17. Brown, A., et al., Blow Fly Lucilia sericata Nuclease Digests DNA Associated with Wound Slough/Eschar and with Pseudomonas aeruginosa Biofilm. Medical and Veterinary Entomology, 2012. 26(4): pp. 432–439, https://doi.org/10.1111/j.1365-2915.2012.01029.x. (opens in new tab)
- 18. Cazander, G., et al., Maggot Excretions Inhibit Biofilm Formation on Biomaterials. Clinical Orthopaedics and Related Research, 2010. 468(10): pp. 2789–2796, https://doi.org/10.1007/s11999-010-1309-5. (opens in new tab)
- 19. Cazander, G., et al., The Influence of Maggot Excretions on PAO1 Biofilm Formation on Different Biomaterials. Clinical Orthopaedics and Related Research, 2009. 467(2): pp. 536–545, https://doi.org/10.1007/s11999-008-0555-2. (opens in new tab)
- 20. Harris, L.G., et al., Disruption of Staphylococcus Epidermidis Biofilms by Medicinal Maggot Lucilia sericata Excretions/Secretions. International Journal of Artificial Organs, 2009. 32(9): pp. 555–564, https://doi.org/10.1177/039139880903200904. (opens in new tab)
- 21. van der Plas, M.J.A., et al., Maggot Excretions/Secretions Are Differentially Effective against Biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 2008. 61(1): pp. 117–122, https://doi.org/10.1093/jac/dkm407. (opens in new tab)
- 22. Davydov, L., Maggot Therapy in Wound Management in Modern Era and a Review of Published Literature. 2011, SAGE Publications: Los Angeles, CA, pp. 89–93.
- 23. Nigam, Y., et al., Maggot Therapy: The Science and Implication for CAM Part II — Maggots Combat Infection. Evidence-based Complementary and Alternative Medicine, 2006. 3(3): pp. 303–308, https://doi.org/10.1093/ecam/nel022. (opens in new tab)
- 24. Contreras-Ruiz, J., et al., [Comparative Study of the Efficacy of Larva Therapy for Debridement and Control of Bacterial Burden Compared to Surgical Debridement and Topical Application of an Antimicrobial]. Gaceta médica de México, 2016. 152(Suppl 2): pp. 78–87, http://www.anmm.org.mx/GMM/2016/s2/GMM_152_2016_S2_78-87.pdf.
- 25. Malekian, A., et al., Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers: A Randomized Controlled Trial. Journal of Wound, Ostomy and Continence Nursing, 2019. 46(1): pp. 25–29, https://doi.org/10.1097/WON.0000000000000496. (opens in new tab)
- 26. Tantawi, T.I., et al., Clinical and Microbiological Efficacy of MDT in the Treatment of Diabetic Foot Ulcers. Journal of Wound Care, 2007. 16(9): pp. 379–383, https://doi.org/10.12968/jowc.2007.16.9.27868. (opens in new tab)
- 27. Armstrong, D.G., et al., Maggot Therapy in “Lower-extremity Hospice” Wound Care: Fewer Amputations and More Antibiotic-free Days. Journal of the American Podiatric Medical Association, 2005. 95(3): pp. 254–257, https://doi.org/10.7547/0950254. (opens in new tab)
- 28. Steenvoorde, P. and J. Oskam, Use of Larval Therapy to Combat Infection after Breast-conserving Surgery. Journal of Wound Care, 2005. 14(5): pp. 212–213, https://doi.org/10.12968/jowc.2005.14.5.26778. (opens in new tab)
- 29. Sherman, R.A. and K.J. Shimoda, Presurgical Maggot Debridement of Soft Tissue Wounds Is Associated with Decreased Rates of Postoperative Infection. Clinical Infectious Diseases, 2004. 39(7): pp. 1067–1070, https://doi.org/10.1086/423806. (opens in new tab)
- 30. Sherman, R., Medicinal Maggot Application and Maggot Therapy Dressing Technology, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 79–96, https://doi.org/10.11647/OBP.0300.05.(opens in new tab)
- 31. Baer, W.S., The Treatment of Chronic Osteomyelitis with the Maggot (Larva of the Blow Fly). The Journal of Bone and Joint Surgery. American Volume, 1931. 13: pp. 438–475, https://doi.org/10.1007/s11999-010-1416-3. (opens in new tab)
- 32. Markevich, Y.O., et al., Maggot Therapy for Diabetic Neuropathic Foot Wounds. Diabetologia, 2000. 43: p. Suppl 1: A15.
- 33. Sherman, R.A., Maggot versus Conservative Debridement Therapy for the Treatment of Pressure Ulcers. Wound Repair and Regeneration, 2002. 10(4): pp. 208–214, https://doi.org/10.1046/j.1524-475X.2002.10403.x. (opens in new tab)
- 34. Sherman, R.A., Maggot Therapy for Treating Diabetic Foot Ulcers Unresponsive to Conventional Therapy. Diabetes Care, 2003. 26(2): pp. 446–451, https://doi.org/10.2337/diacare.26.2.446. (opens in new tab)
- 35. Sherman, R.A., F. Wyle, and M. Vulpe, Maggot Therapy for Treating Pressure Ulcers in Spinal Cord Injury Patients. The Journal of Spinal Cord Medicine, 1995. 18(2): pp. 71–74, https://doi.org/10.1080/10790268.1995.11719382. (opens in new tab)
- 36. European Pressure Ulcer Advisory Panel. National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. The International Guideline. 2019. www.internationalguideline.com/static/pdfs/Quick_Reference_Guide-10Mar2019.pdf.
- 37. Gilead, L., K.Y. Mumcuoglu, and A. Ingber, The Use of Maggot Debridement Therapy in the Treatment of Chronic Wounds in Hospitalised and Ambulatory Patients. Journal of Wound Care, 2012. 21(2): pp. 78–85, https://doi.org/10.12968/jowc.2012.21.2.78. (opens in new tab)
- 38. Mumcuoglu, K.Y., et al., Maggot Therapy for the Treatment of Intractable Wounds: Maggot Therapy for Intractable Wounds Pharmacology and Therapeutics. International Journal of Dermatology, 1999. 38(8): pp. 623–627, https://doi.org/10.1046/j.1365-4362.1999.00770.x. (opens in new tab)
- 39. Polat, E., et al., Treatment of Pressure Ulcers with Larvae of Lucilia sericata. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 2017. 63(4): pp. 307–312, https://doi.org/10.5606/tftrd.2017.851. (opens in new tab)
- 40. Fleischmann, W., et al., Biosurgery — Maggots, Are They Really the Better Surgeons? Chirurg, 1999. 70(11): pp. 1340–1346, https://doi.org/10.1007/s001040050790. (opens in new tab)
- 41. Igari, K., et al., Maggot Debridement Therapy for Peripheral Arterial Disease. Annals of Vascular Diseases, 2013. 6(2): pp. 145–149, https://doi.org/10.3400/avd.oa.13-00036. (opens in new tab)
- 42. Nishijima, A., et al., Effective Wound Bed Preparation Using Maggot Debridement Therapy for Patients with Critical Limb Ischaemia. Journal of Wound Care, 2017. 26(8): pp. 483–489, https://doi.org/10.12968/jowc.2017.26.8.483. (opens in new tab)
- 43. Rafter, L., Larval Therapy Applied to a Large Arterial Ulcer: An Effective Outcome. British Journal of Nursing, 2013. 22(Sup4): pp. S24-S30, https://doi.org/10.12968/bjon.2013.22.Sup4.S24. (opens in new tab)
- 44. Dumville, J.C., et al., Larval Therapy for Leg Ulcers (VenUS II): Randomised Controlled Trial. BMJ, 2009. 338(7702): pp. 1047–1050, https://doi.org/10.1136/bmj.b773.(opens in new tab)
- 45. Mudge, E., et al., A Randomized Controlled Trial of Larval Therapy for the Debridement of Leg Ulcers: Results of a Multicenter, Randomized, Controlled, Open, Observer Blind, Parallel Group Study. Wound Repair and Regeneration, 2014. 22(1): pp. 43–51, https://doi.org/10.1111/wrr.12127. (opens in new tab)
- 46. Wayman, J., et al., The Cost Effectiveness of Larval Therapy in Venous Ulcers. Journal of Tissue Viability, 2000. 10(3): pp. 91–94, https://doi.org/10.1016/S0965-206X(00)80036-4. (opens in new tab)
- 47. Schaper N, et al. IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease. 2019. https://iwgdfguidelines.org/wp-content/uploads/2019/05/IWGDF-Guidelines-2019.pdf.
- 48. Hingorani, A.M.D., et al., The Management of Diabetic Foot: A Clinical Practice Guideline by the Society for Vascular Surgery in Collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of Vascular Surgery, 2016. 63(2): pp. 3S-21S, https://doi.org/10.1016/j.jvs.2015.10.003. (opens in new tab)
- 49. International Diabetes Federation. IDF Diabetes Atlas, 7th Edition. 2015. https://www.idf.org/component/attachments/attachments.html?id=1093&task=download.
- 50. Krishnan, S., et al., Reduction in Diabetic Amputations over 11 Years in a Defined U.K. Population: Benefits of Multidisciplinary Team Work and Continuous Prospective Audit. Diabetes Care, 2008. 31(1): pp. 99–101, https://doi.org/10.2337/dc07-1178. (opens in new tab)
- 51. Marineau, M.L., et al., Maggot Debridement Therapy in the Treatment of Complex Diabetic Wounds. Hawaii Medical Journal, 2011. 70(6): pp. 121–124, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233395/.
- 52. Jun-cheng, W., et al., Maggot Therapy for Repairing Serious Infective Wound in a Severely Burned Patient. Chinese Journal of Traumatology, 2012. 15(2): pp. 124–125, https://doi.org/10.3760/cma.j.issn.1008-1275.2012.02.012.
- 53. Feng, X., et al., Evaluation of the Burn Healing Properties of Oil Extraction from Housefly Larva in Mice. Journal of Ethnopharmacology, 2010. 130(3): pp. 586–592, https://doi.org/10.1016/j.jep.2010.05.044. (opens in new tab)
- 54. Li, Q.M.D., et al., Maggots of Musca Domestica in Treatment of Acute Intractable Wound. Surgery, 2009. 145(1): pp. 122–123, https://doi.org/10.1016/j.surg.2008.08.016. (opens in new tab)
- 55. Namias, N., et al., Biodebridement: A Case Report of Maggot Therapy for Limb Salvage after Fourth-degree Burns. Journal of Burn Care & Rehabilitation, 2000. 21(3): pp. 254–257, https://academic.oup.com/jbcr/article-abstract/21/3/254/4758239?redirectedFrom=fulltext.
- 56. Sherman, R.A., C.E. Shapiro, and R.M. Yang, Maggot Therapy for Problematic Wounds: Uncommon and Off-label Applications. Advances in Skin & Wound Care, 2007. 20(11): pp. 602–610, https://doi.org/10.1097/01.ASW.0000284943.70825.a8. (opens in new tab)
- 57. Summers, J.B. and J. Kaminski, Maggot Debridement Therapy (MDT) for Burn Wounds. Burns: Journal of the International Society for Burn Injuries, 2003. 29(5): pp. 501–502, https://doi.org/10.1016/s0305-4179(03)00059-7. (opens in new tab)
- 58. Vistnes, L.M., R. Lee, and G.A. Ksander, Proteolytic Activity of Blowfly Larvae Secretions in Experimental Burns. Surgery, 1981. 90(5): pp. 835–841.
- 59. McKeever, D.C., Maggots in Treatment of Osteomyelitis: A Simple Inexpensive Method. The Journal of Bone and Joint Surgery, 1933. 15: pp. 85–93, http://dx.doi.org/10.1007/s11999-008-0240-5. (opens in new tab)
- 60. Stewart, M.A., The Therapeutic Behavior of Lucilia Sericata Meig. Larvae in Osteomyelitis Wounds. Science (American Association for the Advancement of Science), 1934. 79(2055): pp. 459–460
- 61. Galeano, M., et al., Maggot Therapy for Treatment of Osteomyelitis and Deep Wounds: An Old Remedy for an Actual Problem [8]. Plastic and Reconstructive Surgery (1963), 2001. 108(7): pp. 2178–2179.
- 62. Horn, K.L., A.H. Cobb, and G.A. Gates, Maggot Therapy for Subacute Mastoiditis. Archives of otolaryngology (1960), 1976. 102(6): pp. 377–379, https://doi.org/10.1001/archotol.1976.00780110089013. (opens in new tab)
- 63. Mumcuoglu, K.Y., et al., [Maggot Therapy for Gangrene and Osteomyelitis]. Harefuah, 1997. 132(5): pp. 323–325, 382.
- 64. Townley, W.A., A. Jain, and C. Healy, Maggot Debridement Therapy to Avoid Prosthesis Removal in an Infected Total Knee Arthroplasty. Journal of Wound Care, 2006. 15(2): pp. 78–79, https://doi.org/10.12968/jowc.2006.15.2.26890. (opens in new tab)
- 65. Wollina, U., M. Kinscher, and H. Fengler, Maggot Therapy in the Treatment of Wounds of Exposed Knee Prostheses. International Journal of Dermatology, 2005. 44(10): pp. 884–886, https://doi.org/10.1111/j.1365-4632.2005.02366c.x. (opens in new tab)
- 66. Beasley, W.D. and G. Hirst, Making a Meal of MRSA—The Role of Biosurgery in Hospital-acquired Infection. 2004, Elsevier Ltd: London, pp. 6–9.
- 67. Bowling, F.L., E.V. Salgami, and A.J.M. Boulton, Larval Therapy: A Novel Treatment in Eliminating Methicillin-Resistant Staphylococcus aureus from Diabetic Foot Ulcers. Diabetes Care, 2007. 30(2): pp. 370–371, https://doi.org/10.2337/dc06-2348. (opens in new tab)
- 68. Dissemond, J., et al., Treatment of Methicillin-resistant Staphylococcus aureus (MRSA) as Part of Biosurgical Management of a Chronic Leg Ulcer. Hautarzt, 2002. 53(9): pp. 608–612, https://doi.org/10.1007/s00105-002-0336-x. (opens in new tab)
- 69. Čeřovský, V. and R. Bém, Lucifensins, the Insect Defensins of Biomedical Importance: The Story behind Maggot Therapy. Pharmaceuticals, 2014. 7(3): pp. 251–264, https://doi.org/10.3390/ph7030251. (opens in new tab)
- 70. Evans, R., E. Dudley, and Y. Nigam, Detection and Partial Characterization of Antifungal Bioactivity from the Secretions of the Medicinal Maggot, Lucilia sericata. Wound Repair and Regeneration, 2015. 23(3): pp. 361–368, https://doi.org/10.1111/wrr.12287. (opens in new tab)
- 71. Margolin, L. and P. Gialanella, Assessment of the Antimicrobial Properties of Maggots. International Wound Journal, 2010. 7(3): pp. 202–204, https://doi.org/10.1111/j.1742-481X.2010.00234.x. (opens in new tab)
- 72. Bohac, M., et al., Maggot Therapy in Treatment of a Complex Hand Injury Complicated by Mycotic Infection. Bratislava Medical Journal, 2015. 116(11): pp. 671–673, https://doi.org/10.4149/bll_2015_128. (opens in new tab)
- 73. Sorensen, M.D. and J.N. Krieger, Fournier’s Gangrene: Epidemiology and Outcomes in the General US Population. Urologia Internationalis, 2016. 97(3): pp. 249–259, https://doi.org/10.1159/000445695. (opens in new tab)
- 74. Angel, K., et al., Madentherapie bei Fournierscher Gangrän — erste Erfahrungen mit einer neuen Therapie. Aktuelle Urologie, 2000. 31(07): pp. 440–443.
- 75. Dunn, C., U. Raghavan, and A.G. Pfleiderer, The Use of Maggots in Head and Neck Necrotizing Fasciitis. The Journal of Laryngology & Otology, 2002. 116(1): pp. 70–72, https://doi.org/10.1258/0022215021910212. (opens in new tab)
- 76. Preuss, S.F., M.J. Stenzel, and A. Esriti, The Successful Use of Maggots in Necrotizing Fasciitis of the Neck: A Case Report. Head & Neck, 2004. 26(8): pp. 747–750, https://doi.org/10.1002/hed.20092. (opens in new tab)
- 77. Steenvoorde, P., et al., Maggot Debridement Therapy in Necrotizing Fasciitis Reduces the Number of Surgical Debridements. Wounds, 2007. 19(3): pp. 73–78.
- 78. Fonseca‐Muñoz, A., et al., Clinical Study of Maggot therapy for Fournier’s Gangrene. International Wound Journal, 2020. 17(6): pp. 1642–1649, https://doi.org/10.1111/iwj.13444. (opens in new tab)
- 79. Berger, S., Tropical Skin Ulcers: Global Status. 2017, Los Angeles: Gideon Informatics, Inc.
- 80. Frimpong, M., et al., Paradoxical Reactions in Buruli Ulcer after Initiation of Antibiotic Therapy: Relationship to Bacterial Load. PLOS Neglected Tropical Diseases, 2019. 13(8): e0007689-e0007689, https://doi.org/10.1371/journal.pntd.0007689. (opens in new tab)
- 81. Eichelmann, K., et al., Leprosy. An update: Definition, Pathogenesis, Classification, Diagnosis, and Treatment. Actas Dermo-Sifiliograficas, 2013. 104(7): pp. 554–563, https://doi.org/10.1016/j.ad.2012.03.003.(opens in new tab)
- 82. Arrivillaga, J., J. Rodríguez, and M. Oviedo, Preliminary Evaluation of Maggot (Diptera: Calliphoridae) Therapy as a Potential Treatment for Leishmaniasis Ulcers. Biomédica, 2008. 28(2): pp. 305–310, https://doi.org/10.7705/biomedica.v28i2.102. (opens in new tab)
- 83. Cruz-Saavedra, L., et al., The Effect of Lucilia sericata- and Sarconesiopsis magellanica-derived Larval Therapy on Leishmania panamensis. Acta Tropica, 2016. 164: pp. 280–289, https://doi.org/10.1016/j.actatropica.2016.09.020. (opens in new tab)
- 84. Polat, E., et al., Detection of Anti-leishmanial Effect of the Lucilia sericata Larval Secretions in vitro and in vivo on Leishmania tropica: First work. Experimental Parasitology, 2012. 132(2): pp. 129–134, https://doi.org/10.1016/j.exppara.2012.06.004. (opens in new tab)
- 85. Sanei-Dehkordi, A., et al., Anti Leishmania Activity of Lucilia sericata and Calliphora vicina Maggots in Laboratory Models. Experimental Parasitology, 2016. 170: pp. 59–65, https://doi.org/10.1016/j.exppara.2016.08.007. (opens in new tab)
- 86. Stadler, F., R.Z. Shaban, and P. Tatham, Maggot Debridement Therapy in Disaster Medicine. Prehospital and Disaster Medicine, 2016. 31(1): pp. 79–84, https://doi.org/10.1017/S1049023X15005427. (opens in new tab)
- 87. Čičková, H., M. Kozánek, and P. Takáč, Growth and Survival of Blowfly Lucilia sericata Larvae under Simulated Wound Conditions: Implications for Maggot Debridement Therapy. Medical and Veterinary Entomology, 2015. 29(4): pp. 416–424, https://doi.org/10.1111/mve.12135. (opens in new tab)
- 88. Stadler, F. and P. Tatham, Drone-assisted Medicinal Maggot Distribution in Compromised Healthcare Settings, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 383–402, https://doi.org/10.11647/OBP.0300.18.(opens in new tab)
- 89. Ayello, E.A., et al., Reexamining the Literature on Terminal Ulcers, SCALE, Skin Failure, and Unavoidable Pressure Injuries. Advances in Skin & Wound Care, 2019. 32(3): pp. 109–121, https://doi.org/10.1097/01.ASW.0000553112.55505.5f. (opens in new tab)
- 90. Steenvoorde, P., et al., Maggot Debridement Therapy in the Palliative Setting. American Journal of Hospice & Palliative Medicine, 2007. 24(4): pp. 308–310, https://doi.org/10.1177/1049909107302300. (opens in new tab)
- 91. Brüggmann, D., H.R. Tinneberg, and M.T. Zygmunt, [Maggot Therapy in Gynecology]. Zentralblatt für Gynäkologie 2006. 128(5): pp. 261–265, https://doi.org/10.1055/s-2006-942121. (opens in new tab)
- 92. Wolters, U., et al., ASA Classification and Perioperative Variables as Predictors of Postoperative Outcome. British Journal of Anaesthesia, 1996. 77(2): Pp. 217–222, https://doi.org/10.1093/bja/77.2.217. (opens in new tab)
- 93. Peck, G.W. and B.C. Kirkup, Biocompatibility of Antimicrobials to Maggot Debridement Therapy: Medical Maggots Lucilia sericata (Diptera: Calliphoridae) Exhibit Tolerance to Clinical Maximum Doses of Antimicrobials. Journal of Medical Entomology, 2012. 49(5): pp. 1137–1143, https://doi.org/10.1603/ME12066. (opens in new tab)
- 94. Sherman, R.A., F.A. Wyle, and L. Thrupp, Effects of Seven Antibiotics on the Growth and Development of Phaenicia sericata (Diptera: Calliphoridae) Larvae. Journal of Medical Entomology, 1995. 32(5): pp. 646–649, https://doi.org/10.1093/jmedent/32.5.646. (opens in new tab)
- 95. Felder, J.M., et al., Increasing the Options for Management of Large and Complex Chronic Wounds with a Scalable, Closed-system Dressing for Maggot Therapy. Journal of Burn Care & Research, 2012. 33(3): pp. e169-e175, https://doi.org/10.1097/BCR.0b013e318233570d. (opens in new tab)
- 96. Sherman, R.A., B. Khavari, and D. Werner, Effect of Hyperbaric Oxygen on the Growth and Development of Medicinal Maggots. Undersea and Hyperbaric Medicine, 2013. 40(5): pp. 377–380.
- 97. Teich, S. and R.A.M. Myers, Maggot Therapy for Severe Skin Infections. Southern Medical Journal, 1986. 79(9): pp. 1153–1155.
- 98. Rojo, S. and S. Geraghty, Hemophilia and Maggots: From Hospital Admission to Healed Wound. Ostomy Wound Management, 2004. 50(4): pp. 30, 32, 34.
- 99. Sherman, R.A. and M.R. Hetzler, Maggot Therapy for Wound Care in Austere Environments. Journal of Special Operations Medicine, 2017. 17(2): pp. 154–162.
- 100. Grassberger, M. and C. Reiter, Effect of Temperature on Lucilia sericata (Diptera: Calliphoridae) Development with Special Reference to the Isomegalen- and Isomorphen-diagram. Forensic Science International, 2001. 120(1): pp. 32–36, https://doi.org/10.1016/S0379-0738(01)00413-3. (opens in new tab)
- 101. Sherman, R.A., et al., Effects of Food Storage and Handling on Blow Fly (Lucilia sericata) Eggs and Larvae. Journal of Food Science, 2006. 71(3): pp. M117-M120, https://doi.org/10.1111/j.1365-2621.2006.tb15634.x. (opens in new tab)
- 102. Gallagher, M.B., S. Sandhu, and R. Kimsey, Variation in Developmental Time for Geographically Distinct Populations of the Common Green Bottle Fly, Lucilia sericata (Meigen). Journal of Forensic Sciences, 2010. 55(2): pp. 438–442, https://doi.org/10.1111/j.1556-4029.2009.01285.x. (opens in new tab)
- 103. Richards, C.S. and M.H. Villet, Data Quality in Thermal Summation Development Models for Forensically Important Blowflies. Medical and Veterinary Entomology, 2009. 23(3): pp. 269–276, https://doi.org/10.1111/j.1365-2915.2009.00819.x. (opens in new tab)
- 104. Mirabzadeh, A., et al., Maggot Therapy for Wound Care in Iran: A Case Series of the First 28 Patients. Journal of Wound Care, 2017. 26(3): pp. 137–143, https://doi.org/10.12968/jowc.2017.26.3.137. (opens in new tab)
- 105. Lin, G., et al., Hard Times Call for Creative Solutions: Medical Improvisations at the Israel Defense Forces Field Hospital in Haiti. American Journal of Disaster Medicine, 2010. 5(3): pp. 188–192.
